Reporter Gene Assay Global Market Report 2025

A reporter gene assay is a molecular biology technique employed to investigate gene expression and regulatory sequences. It utilizes a reporter gene, which encodes a measurable product.

The primary types of products in the reporter gene assay market include assay kits and reagents. Assay kits play a pivotal role in scientific research and clinical diagnostics by offering a consistent, reliable, and often high-throughput method for conducting intricate tests. These kits find diverse applications such as promoter structural and functional analysis, examination of cell signaling pathways, protein interaction studies, clinical diagnostics, and gene regulation. They are utilized by various end-users including biotechnology and pharmaceutical firms, research and academic institutions, hospital and diagnostic laboratories, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The reporter gene assay market research report is one of a series of new reports from The Business Research Company that provides reporter gene assay market statistics, including reporter gene assay industry global market size, regional shares, competitors with a reporter gene assay market share, detailed reporter gene assay market segments, market trends and opportunities, and any further data you may need to thrive in the reporter gene assay industry. This reporter gene assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The reporter gene assay market size has grown strongly in recent years. It will grow from $6.39 billion in 2024 to $6.93 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for cell-based assays, rise in genomics research, increased drug discovery and development research, rising need for personalized treatment, and demand for early diagnosis.

The reporter gene assay market size is expected to see strong growth in the next few years. It will grow to $9.57 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the rising prevalence of chronic genetic disorders, growing demand for personalized medicine, growing use of molecular imaging systems, expansion of gene therapy portfolios, and government initiatives. Major trends in the forecast period include technological advancements in gene therapy, advancements in molecular biology, demand for advanced molecular diagnostic tools, shift towards 3d cell culture models, and strategic partnerships.

The forecast of 8.4% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. research institutions by inflating prices of luciferase-based detection kits and fluorescent substrates developed in Switzerland and Japan, resulting in delayed drug discovery timelines and higher molecular biology research costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the reporter gene assay market is expected to be fueled by the expanding drug discovery and development research. This research refers to the systematic process within the fields of medicine, biotechnology, and pharmacology, aimed at identifying, creating, and bringing new drugs to market. The rise in drug discovery and development research is driven by advances in proteomics, high-throughput screening, genomics, and the successful development and approval of new medications. Reporter gene assays play a critical role in this process, providing valuable insights into gene regulation, helping to identify potential drug targets, screen compound libraries, and assess the efficacy and safety of candidate drugs. For example, in May 2024, the National Science Foundation, a US government agency, reported that in 2022, the United States invested approximately $885.6 billion in research and development (R&D), marking a 12% increase from 2021 in current (nominal) dollars and a 5% increase when adjusted for inflation (constant dollars). This growing investment in drug discovery and development research is a key driver for the expansion of the reporter gene assay market.

Leading companies in the reporter gene assay market are concentrating on innovative solutions such as ultrasensitive multiplexed digital PCR assays to enhance their market position. These assays, such as Bio-Rad Laboratories Inc.'s ddPLEX ESR1 Mutation Detection Kit launched in April 2024, detect and quantify nucleic acids with high precision by dividing samples into numerous reactions containing minute amounts of target DNA or RNA molecules. This ultrasensitive assay offers exceptional sensitivity for detecting minor mutations in complex samples, particularly beneficial for early disease monitoring in breast cancer. Its multiplexing capability allows simultaneous detection of multiple mutations, streamlining testing and potentially transforming breast cancer research and personalized treatment strategies.

In January 2023, Qiagen N.V., a German biotechnology company, acquired Verogen Inc. to strengthen its footprint in forensic genomics and DNA analysis. This acquisition integrates Verogen's specialized sequencing technologies and analysis software tailored for forensic applications into Qiagen's portfolio, expanding its capabilities in this specialized field. Verogen Inc. is a US-based company providing reporter gene assays.

Major companies operating in the reporter gene assay market are Roche Diagnostics, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD Biosciences), GE Healthcare, Lonza Group, Agilent Technologies, Sartorius AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GenScript Biotech Corporation, Abcam plc, Promega Corporation, Promega Corporation, Takara Bio Inc., New England Biolabs (NEB), OriGene Technologies Inc., Cell Signaling Technology Inc., SABiosciences, Enzo Biochem Inc., InvivoGen, Biotium Inc., Enzo Life Sciences Inc., BioAssay Systems, Indigo Biosciences Inc.

North America was the largest region in the reporter gene assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reporter gene assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reporter gene assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reporter gene assay market consists of revenues earned by entities by providing services such as cell culture services, assay development, assay validation, high-throughput screening, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The reporter gene assay market also includes consists sales of transfection reagents, reporter gene detection kits, assay validation controls, assay optimization kits, and high-throughput screening platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Reporter Gene Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on reporter gene assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reporter gene assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reporter gene assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Assay Kits; Reagents
• 2) By Application: Promoter Structural And Functional Analysis; Cell Signaling Pathways; Protein Interaction; Clinical And Gene Regulation
• 3) By End-User: Biotechnology And Pharmaceutical Companies; Research And Academic Institutes; Hospital And Diagnostic Laboratories; Contract Research Organizations
• Subsegments:
• 1) By Assay Kits: Luciferase Reporter Assay Kits; B-galactosidase Reporter Assay Kits; Fluorescent Reporter Assay Kits; Secreted Alkaline Phosphatase (SEAP) Assay Kits
• 2) By Reagents: Luciferase Substrates; B-galactosidase Substrates; Fluorescent Proteins; Detection Buffers And Enhancers
• Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Becton Dickinson and Company (BD Biosciences); GE Healthcare; Lonza Group; Agilent Technologies; Sartorius AG; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; GenScript Biotech Corporation; Abcam plc; Promega Corporation; Promega Corporation; Takara Bio Inc.; New England Biolabs (NEB); OriGene Technologies Inc.; Cell Signaling Technology Inc.; SABiosciences; Enzo Biochem Inc.; InvivoGen; Biotium Inc.; Enzo Life Sciences Inc.; BioAssay Systems; Indigo Biosciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.